Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

NCT02412787 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hunter Syndrome

Interventions

DRUG: Idursulfase-IT
DRUG: Elaprase

Sponsor

Shire